
Michael Scherer
Staff writer at The Atlantic and political reporter with expertise in national security and presidential politics, contributing analysis and firsthand reporting.
Top 3 podcasts with Michael Scherer
Ranked by the Snipd community

20 snips
Jan 5, 2026 • 32min
Is the U.S. Running Venezuela or Not?
In a compelling discussion, Michael Scherer, a political reporter at The Atlantic, and Vivian Salama, a foreign policy journalist specializing in Latin America, dissect the recent U.S. raid on Venezuela. They analyze President Trump's shifting rhetoric and what it really means for U.S. involvement. Salama highlights the ambiguous role of Delcy Rodríguez and the challenges of a post-Maduro Venezuela, including the tangled web of political opposition and economic crises. Scherer connects this to Trump's broader strategy for hemispheric control and influence.

11 snips
Dec 11, 2025 • 31min
How RFK Jr.’s tumultuous past has shaped his convictions
Michael Scherer, a staff writer for The Atlantic, dives into the complexities of Robert F. Kennedy Jr.'s life and his evolving role as Health and Human Services Secretary. He discusses Kennedy's early trauma, his fight against addiction, and how these experiences have shaped his controversial approaches to public health. Scherer also explores Kennedy's shift in political alliances, his scrutiny of vaccination policies, and the implications of his focus on parental autonomy in health decisions. The conversation reveals the layers behind Kennedy's convictions and their impact on public discourse.

9 snips
Nov 29, 2025 • 22min
Washington Week with The Atlantic full episode, 11/28/25
In this insightful discussion, guests break down the complex role of Robert F. Kennedy Jr. in shaping American health policy. Michael Scherer reveals Kennedy's evolution and his significant political value to Trump. Dan Diamond highlights the shared vaccine skepticism between the two, while Julie Rovner examines the troubling impacts of staff cuts at HHS and the CDC’s leadership struggles. The conversation also touches on the political pressures faced by the FDA and the long-term ramifications of the pandemic on public trust in health experts.


